googlemarker
Open An Account
Secure With Us
Refer a Friend
Trade on Mobile

IPO SnapShot

Gland Pharma Ltd.
Issue Open Date 09-Nov-20  
Issue Closing Date 11-Nov-20  
Application Money 100  
Allotment Money  
Price Band (Rs.) 1490 - 1500  
Minimum Bid Quantity. 10  
Issue Size (Shares) 30237879  
Market Lot 1  
Objective :

To finance the incremental working capital requirements of our CompanyTo meet funding requirements for capital expenditure requirementsTo meet the general corporate purposes

Business Description

Promoter's Holding
Total Share Capital   114662620  
Offered to Public   43196968  
Promoter's Holding (Pre-Issue)   74  
Promoter's Holding (Post-Issue)   70.22  
Address
Survey No. 143-148
150 & 151
Near Gandimaisamma 'x' Roads
D. P. Pally
Dundigal Gandimaisamma Mandal
Medchal-malkajgiri District
Hyderabad ,
Telangana ,
500043
Phone : 040 3051 0999
Email : gland@glandpharma.com
Website : www.glandpharma.com
Registrar
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
Citigroup Global Markets India Pvt Ltd.
Haitong Securities India Pvt Ltd.
Kotak Mahindra Capital Co Ltd
Nomura Financial Advisory & Securities (India) Pvt Ltd.
Promoters
Fosun Pharma Industrial Pte. Ltd.
Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ000198838  | 
  • BSE- INZ000198838  | 
  • MCX- INZ000198838  | 
  • NCDEX- INZ000198838  | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     54494